Trabectedin in Soft Tissue Sarcomas
Soft tissue sarcomas are a group of rare tumors derived from mesenchymal tissue, accounting for about 1% of adult cancers. There are over 60 different histological subtypes, each with their own unique biological behavior and response to systemic therapy. The outcome for patients with metastatic soft...
Main Authors: | Petek, Bradley J., Loggers, Elizabeth T., Pollack, Seth M., Jones, Robin L. |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344612/ |
Similar Items
-
Pazopanib in the management of advanced soft tissue sarcomas
by: Cranmer, Lee D, et al.
Published: (2016) -
The value of trabectedin in the treatment of soft tissue sarcoma
by: Nakamura, Tomoki, et al.
Published: (2016) -
Trabectedin for advanced soft tissue sarcomas: optimizing use
by: Reid, Alison, et al.
Published: (2014) -
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar, Ingrid M E, et al.
Published: (2016) -
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
by: Gordon, Erlinda M., et al.
Published: (2016)